Mark Mansfield
Contributor since: 2009
Company: Mark's Market Analysis
Latest Articles
Ryder Systems: Solid - Yet Overlooked - Transportation Company
Why I Think Deere Is a Buy Ahead of Earnings
Human Genome: Buy the Pipeline Before Glaxo Does
Why Molycorp Is a Buy Despite Its Sticker Price
Why I'm Maintaining My Long Position in Coinstar
Growing Signs That We May Be on the Verge of a Correction
Coinstar Slides Again After Earnings Announcement: Is There Still Hope?
Cigna: Don't Be Alarmed by Soft Guidance
Delcath Systems Begins to Run Ahead of FDA NDA Response
A Protected Play on Broadcom
Orexigen Options: A Lesson in Trading Biotech
Why I Am Short Caterpillar
Coinstar: Short-Term Has Only One Direction to Go
Why Molycorp Is a Short Through Next Week
Medtronic Drops the Ball on Pacemakers
Dangerous Developments in U.S. Creditworthiness
Why I See the Ireland Bailout Failing
Why Obama's Capital Investment Write-Off Will Do Little
A Wild Wednesday and a Coming Global Crash?
5 Reasons the Bears Brought the Market Down
Why China's Yuan Revaluation Isn't That Exciting
A Summation of Bleak Global Economic Evidence
Bank Liquidity Strains in China?
Five Possible Outcomes for Greece
Walter Energy: Overvalued and Overbought
Matrixx Initiatives: A Critical Test of Crisis Management